MALNUTRITION AS A PROGNOSTIC FACTOR IN LYMPHOBLASTIC-LEUKEMIA - A MULTIVARIATE-ANALYSIS

被引:111
作者
VIANA, MB
MURAO, M
RAMOS, G
OLIVEIRA, HM
DECARVALHO, RI
DEBASTOS, M
COLOSIMO, EA
SILVESTRINI, WS
机构
[1] UNIV FED MINAS GERAIS,DIV HAEMATOL,BELO HORIZONT,MG,BRAZIL
[2] UNIV FED MINAS GERAIS,HOSP CLIN,DIV HAEMATOL,BELO HORIZONT,MG,BRAZIL
[3] FELICIO ROCHO HOSP,BELO HORIZONT,MG,BRAZIL
[4] IPSEMG BASE HOSP,BELO HORIZONT,MG,BRAZIL
[5] UNIV FED MINAS GERAIS,DEPT STAT,BELO HORIZONT,MG,BRAZIL
[6] ESCOLA PAULISTA MED,DEPT PAEDIAT,SAO PAULO,BRAZIL
关键词
D O I
10.1136/adc.71.4.304
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
One hundred and twenty eight Brazilian children with lymphoblastic leukaemia were intensively treated with a Berlin-Frankfurt-Munich based protocol. More children had a white cell count above 50 x 10(9)/1 (31%) then observed in developed countries. After a median follow up of 31 months (11-58 months), the estimated probability of relapse free survival was 41% (7%) for the whole group. After adjustment in the Cox's multivariate model, malnutrition was the most significant adverse factor affecting duration of complete remission. Age above 8 years and high peripheral white cell count were also significant adverse factors. Among the nutritional indices, the height for age and weight for age z scores were both significant, whether the cut off points of z-2 or z = -1.28 were chosen to define malnutrition. A strong statistical association between the two indices was found; the contribution of height for age z score to the prediction of relapse free survival was more significant. Children with height for age z score < -2 had a relapse risk of 8.2 (95% confidence interval 3.1 to 21.9) relative to children with z score > -2. The results of this study suggest that socioeconomic and nutritional factors should be considered in the prognostic evaluation of children with leukaemia in developing countries.
引用
收藏
页码:304 / 310
页数:7
相关论文
共 33 条
[31]  
SZKLO M, 1978, CANCER, V42, P59, DOI 10.1002/1097-0142(197807)42:1<59::AID-CNCR2820420109>3.0.CO
[32]  
2-J
[33]  
1986, B WORLD HEALTH ORGAN, V64, P929